Creso Pharma Signs Agreement to Acquire Established Canadian Psychedelics Company Halucenex Life Sciences Inc.

CANNANNEW REPORT

Halucenex is a Psychedelic-Assisted Psychotherapy (PAP) company ‍ • Halucenex focuses on the commercialisation and R&D of novel psychedelic molecules… Read More….. The post Creso Pharma Signs Agreement to Acquire Established Canadian Psychedelics Company Halucenex Life Sciences Inc. appeared first on Cannabis Law Report.

Excerpt only …
READ MORE BELOW
Source : Creso Pharma Signs Agreement to Acquire Established Canadian Psychedelics Company Halucenex Life Sciences Inc.

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.